Crucell licences STAR technology to Novo Nordisk |
|
|
|
Published
:
Tue, 16 Jan 2007 08:36 |
AMSTERDAM (AFX) - Crucell NV has licenced its STAR technology to Denmark-based Novo Nordisk, the company said in a statement.No financial details were disclosed.Novo Nordisk will use the technology to evaluate its proprietary mammalian CHO cell line and antibodies, Crucell said.mike.croall@afxnews.commc/twCOPYRIGHTCopyright AFX News Limited 2006. All rights reserved.The copying, republication or redistribution of AFX News Content, including by framing or similar means, is expressly prohibited without the prior written consent of AFX News.AFX News and AFX Financial News Logo are registered trademarks of AFX News Limited
|
|
|
|
|
|
|
| Stock
Quotes * |
|
NASDAQ
|
|
2792.28 |
22.57 (
0.81 %)
|
| SYMBOL (
2012-01-19 ) |
| LAST |
CHANGE
|
|
CARNIVAL
(
11:35am )
|
|
2017.00 |
46.00 (
2.42 %)
|
|
WHITBREAD
(
11:35am )
|
|
1662.99 |
33.99 (
2.09 %)
|
| SYMBOL (
2012-01-19 )
|
| LAST |
CHANGE
|
|
IBM
(
12:34pm ) |
|
181.50 |
0.43 (
0.24 %)
|
| SYMBOL (
2012-01-19 )
|
| LAST |
CHANGE
|
|
| Portfolio
Manager |
|
|
|